Cognex Corporation
CGNX Technology Scientific & Technical Instruments
Cognex Corporation’s revenue for fiscal 2025 (year ended December 2025) was $994.4 million, up 8.73% from fiscal 2024.
- Revenue
- +16.9%
- EPS
- +79.2%
- Free cash flow
- +67.3%
Quarter to June 2026, against a year earlier
Follow CGNX
Alert me
Cognex Corporation (CGNX) Return on equity
Cognex Corporation's return on equity over the twelve months to 30 June 2026 was 11.2%, up 3.5 percentage points from fiscal 2025 (7.61%). Over the past ten years it has ranged from 7.03% (fiscal 2024) to 24.0% (fiscal 2015); the current reading is higher than 18% of that period. That is above the Scientific & Technical Instruments industry median of 2.66% and above the Technology sector median of 0.00%.
Return on equity, annual
Embed this chart
Annual newest first
| Period | Return on equity | Change (points) |
|---|---|---|
| FY2025 | 7.61% | 0.58 |
| FY2024 | 7.03% | (0.66) |
| FY2023 | 7.69% | (7.34) |
| FY2022 | 15.0% | (5.76) |
| FY2021 | 20.8% | 7.33 |
| FY2020 | 13.5% | (2.91) |
| FY2019 | 16.4% | (3.29) |
| FY2018 | 19.7% | 2.49 |
| FY2017 | 17.2% | 1.10 |
| FY2016 | 16.1% | (7.88) |
Against its own ten years
Return on equity against peers
| Company | Return on equity |
|---|---|
| VNT Vontier Corporation compare | 28.9% |
| ESE ESCO Technologies Inc. compare | 21.4% |
| BMI Badger Meter, Inc. compare | 18.7% |
| MKSI MKS Inc. compare | 15.9% |
| ST Sensata Technologies Holding N.V. compare | 12.7% |
| CGNX Cognex Corporation | 11.2% |
| FTV Fortive Corporation compare | 10.5% |
| NOVT Novanta Inc. compare | 5.11% |
| TRMB Trimble Inc. compare | −1.94% |
| Scientific & Technical Instruments industry median | 2.66% |
| Technology sector median | 0.00% |
| Market median | 1.07% |
What Return on equity is
ROE shows how much profit a company earns for its shareholders on the equity they have in the business.
Annual: Net Income Allotted to Shareholders ÷ Average Common Equity; TTM: Net Income Allotted to Shareholders ÷ Average Common Equity (latest quarter)
More on CGNX
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement